Form 8-K - Current report:
SEC Accession No. 0001104659-25-065972
Filing Date
2025-07-07
Accepted
2025-07-07 07:31:46
Documents
13
Period of Report
2025-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519927d1_8k.htm   iXBRL 8-K 32100
2 EXHIBIT 10.1 tm2519927d1_ex10-1.htm EX-10.1 132180
  Complete submission text file 0001104659-25-065972.txt   365813

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20250707.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20250707_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20250707_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2519927d1_8k_htm.xml XML 3556
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 251106987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)